SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)

Deleporte, Amélie; Hendlisz, Alain; Garcia, Camilo; Delaunoit, Thierry; Maréchal, Raphaël; Peeters, Marc; Holbrechts, Stéphane; Van den Eynde, Marc; Houbiers, Ghislain; Filleul, Bertrand; Van Laethem, Jean Luc; Ceyssens, Sarah; Barbuto, Anna Maria; Lhommel, Renaud; Demolin, Gauthier; Moreau, Michel; Paesmans, Marianne; Piccart, Martine; Flamen, Patrick

SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC)

Deleporte, Amélie

;

Hendlisz, Alain

;

Garcia, Camilo

;

Delaunoit, Thierry

;

Flamen, Patrick

;et.al.

(2012) ASCO Annual Meeting — Location: Chicago, Illinois (1.June.2012)

Files

No attached file found for this publication.

Details

Authors

Deleporte, Amélie
Author
Hendlisz, Alain
Author
Garcia, Camilo
Author
Delaunoit, Thierry
Author
Van den Eynde, MarcUCLouvain
Author
Lhommel, RenaudUCLouvain
Author
Flamen, Patrick
Author

Affiliations

Citations

APA
Chicago
FWB

Deleporte, A., Hendlisz, A., Garcia, C., Delaunoit, T., Maréchal, R., Peeters, M., Holbrechts, S., Van den Eynde, M., Houbiers, G., Filleul, B., Van Laethem, J. L., Ceyssens, S., Barbuto, A. M., Lhommel, R., Demolin, G., Moreau, M., Paesmans, M., Piccart, M., & Flamen, P. (2012). SoMore trial:Prospective multicentric clinical and metabolic assessment of a sorafenib(SOR)-capecitabine(CAP)combination in patients with chemorefractory advanced colorectal cancer(aCRC). ASCO Annual Meeting Proceedings, Abstract #96531. https://hdl.handle.net/2078.5/163880 (Original work published 2012)